During the past decade, Altana Pharma/Nycomed conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Altana Pharma/Nycomed" #1 collaborator was "Nycomed GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Altana Pharma/Nycomed" are "Asthma" (15 trials), "GERD" (2 trials), "Gastroesophageal Reflux" (2 trials), "Gastroesophageal Reflux Disease" (2 trials) and "Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Altana Pharma/Nycomed" in a lesser frequency.

Most popular intervention types in "Altana Pharma/Nycomed" are "Drug" (24 trials). Other intervention types were less common.

The name of intervention was led by "Ciclesonide" (15 trials), "Pantoprazole" (6 trials), "Placebo" (4 trials), "Ciclesonide/Formoterol Combination" (1 trials) and "Fluticasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Altana Pharma/Nycomed" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Altana Pharma/Nycomed". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Altana Pharma/Nycomed, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Altana Pharma/Nycomed, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".